). α-tubulins ing. Here, we show that E2F6 plays an unexpected are highly expressed in many cell types, and subtypeand essential role in the tissue specificity of gene exspecific antibodies do not exist, which impedes a spepression. E2F6-deficient mice ubiquitously express cific analysis of TUBA3 and TUBA7 proteins. Immunothe ␣-tubulin 3 and 7 genes, which are expressed fluorescence analysis with a pan-α-tubulin antibody strictly testis-specifically in control mice. Like an adrevealed neither quantitative nor qualitative differences ditional E2F6 target gene, Tex12, that we identified, in the microtubuli structure of E2F6 −/− versus control tubulin 3 and 7 are normally expressed in male germ
tantly expressed E2F6. In E2F6 −/− mice, TUBA3 and TUBA7 expression had lost its tissue specificity, and high levels of transcripts were detected in all organs A recent study found the TUBA3/7 genes not to be expressed in somatic cells of the testis but rather in analyzed. In testis, the expression levels of TUBA3 and TUBA7 were similar in control and E2F6 −/− animals (in male germ cells, namely the spermatogonia that constitute the self-renewing, mitotic germ cells of the testis relation to the β-actin control). This might indicate that the expression of TUBA3 and TUBA7 in normal testis is [11] . The same study also described several other spermatogonia-expressed genes that were not represented achieved by preventing the E2F6-mediated repression. We conclude from this set of experiments that E2F6 is on the Affymetrix microarray used here. Out of this set of genes, we found the Tex12 gene (for testisessential for the repression of the TUBA3 and TUBA7 genes in nontesticular tissues, implying a role for E2F6 expressed 12) to be also derepressed in E2F6 −/− MEFs ( Figure 3A) . In contrast, the expression of several other in establishing tissue-specific patterns of gene expression.
spermatogonia-expressed genes was absent from both data, our microarray analysis also did not identify typical E2F target genes to be deregulated in E2F6-deficient MEFs. Therefore, our data suggest that E2F6 is not required for the regulation of an E2F-driven program of cell-cycle-dependent gene expression. This is further supported by the finding that the overall cellcycle control of E2F6 −/− MEFs is unperturbed when compared to wt MEFs ( Figure 3C ; data not shown). Also, both cell types reentered the cell cycle after serum starvation with similar kinetics (Figure 3D) , which is consistent with a previous study [13] . In conclusion, E2F6 is not required for the correct expression of E2F-responsive cell-cycle genes.
The TUBA3 and TUBA7 promoters are well conserved and lack canonical TATA sequences ( Figure 4A (data not shown) . Consistent with these a band shift assay to date, possibly owing to the instability of such complexes under electrophoresis conditions. To overcome this limitation, we covalently coupled double-stranded DNA oligonucleotides containing the TUBA7 E2F binding site (or a mutant site) to sepharose and used this for affinity chromatography. The affinity-chromatography columns were loaded with wholecell extracts (Figure 4D, lane1) and washed. Bound proteins were eluted with high salt and analyzed by Western blotting. Under these experimental conditions, an interaction of endogenous E2F6 with the wt (lanes 2-5) but not the mutant (lanes 7-10) TUBA7 E2F site can readily be observed. In addition, E2F4 also binds to the column in an E2F-site-specific manner, but the unrelated transcription factor Sp1 does not. Thus, both overexpressed and endogenous E2F6 can specifically bind to the TUBA3 E2F site.
Given that several E2F family members are able to bind to the TUBA3 E2F site in vitro, we next analyzed the occupancy of this site in vivo. Employing the genomic footprinting methodology [16] , we show that at times when this promoter is active in E2F6 −/− MEFs, the E2F site is protected, indicating the association of endogenous transacting factors with this DNA element ( Figure 5A ). Also, additional footprints protecting a CCAAT box and a predicted Sp1 binding site clearly indicate that the TUBA3 promoter (including the E2F site) is bound by sequence-specific factors in vivo. In contrast, none of these sites were occupied to a significant degree in wt MEFs, and, moreover, no other protected sequence elements could be detected. In addition, the hypersensitive site observed in E2F6 −/− MEFs at position −148 was absent from the repressed promoter. These data indicate that in wt fibroblasts, when the TUBA3 gene is silent, the promoter is not occupied to an appreciable extent by transacting factors but that it "opens up" in E2F6 −/− MEFs, leading to factor accessibility that in turn correlates with active transcription. Consistent with the lack of E2F site occupancy of the repressed TUBA3 promoter, we were unable to detect significant E2F6 (or E2F1) binding to the TUBA3 promoter in wt fibroblasts by ChIP ( Figure 5B ). However, we could readily detect binding of the transactivating factors E2F1 and Sp1 to the TUBA3 gene promoter in E2F6 −/− MEFs ( Figure 5B ), which is again in close agreement with the in vivo footprinting pattern and the activity of the TUBA3 promoter in these cells.
The finding that the TUBA3 promoter is obviously not 
